Clémence Henon
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
Papers in
-
- Sarcoma Diagnosis and Treatment 14
- Brain Metastases and Treatment 3
-
- Gastrointestinal Tumor Research and Treatment 6
- Co-authors
- Sophie Postel‐Vinay (3 shared papers)Axel Le Cesne (8 shared papers)Jean‐Charles Soria (2 shared papers)Christophe Massard (4 shared papers)Julien Adam (3 shared papers)Jean‐Yves Blay (5 shared papers)Rastislav Bahleda (3 shared papers)Olivier Mir (2 shared papers)
- Journals
- Annals of Oncology (6 papers)ESMO Open (6 papers)Cancer Research (2 papers)European Journal of Cancer (2 papers)Cancer Treatment Reviews (2 papers)
- Partner nations
- FranceSpainUnited Kingdom
In The Last Decade
Clémence Henon
37 papers receiving 1.7k citations
Clémence Henon's Hit Papers
Peers
Comparison fields: 5 of 86
- Infectious Diseases 417
- Oncology 520
- Immunology 400
- Neurology 215
- Pulmonary and Respiratory Medicine 366
Countries citing papers authored by Clémence Henon
This map shows the geographic impact of Clémence Henon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémence Henon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémence Henon more than expected).
Fields of papers citing papers by Clémence Henon
This network shows the impact of papers produced by Clémence Henon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémence Henon. The network helps show where Clémence Henon may publish in the future.
Co-authors
The 25 scholars most cited alongside Clémence Henon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 Hit paper breakdown → | 2020 | 620 |
| 2 | 2018 | 274 | |
| 3 | 2019 | 198 | |
| 4 | 2020 | 101 | |
| 5 | 2021 | 98 | |
| 6 | 2019 | 93 | |
| 7 | 2019 | 52 | |
| 8 | 2024 | 39 | |
| 9 | 2023 | 27 | |
| 10 | 2022 | 24 | |
| 11 | 2017 | 23 | |
| 12 | 2024 | 22 | |
| 13 | 2023 | 20 | |
| 14 | 2023 | 15 | |
| 15 | 2024 | 14 | |
| 16 | 2019 | 12 | |
| 17 | 2024 | 12 | |
| 18 | 2022 | 11 | |
| 19 | 2017 | 10 | |
| 20 | 2024 | 9 |
About Clémence Henon
Clémence Henon is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Oncology, Pathology and Forensic Medicine and Immunology, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Cancer Genomics and Diagnostics (3 papers), HER2/EGFR in Cancer Research (3 papers), Brain Metastases and Treatment (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Lung Cancer Research Studies (2 papers) and Cardiac tumors and thrombi (2 papers). The work is most often cited by research in Infectious Diseases (417 citations), Oncology (520 citations), Immunology (400 citations), Neurology (215 citations) and Pulmonary and Respiratory Medicine (366 citations). Clémence Henon has collaborated with scholars based in France, Spain and United Kingdom. Frequent co-authors include Sophie Postel‐Vinay, Axel Le Cesne, Jean‐Charles Soria, Christophe Massard, Julien Adam, Jean‐Yves Blay, Rastislav Bahleda, Olivier Mir, Sarah Dumont and Cecile Le Pechoux. Their work appears in journals such as Annals of Oncology, ESMO Open, Cancer Research, European Journal of Cancer and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.